Package 62332-467-04

{"route": ["TOPICAL"], "spl_id": "d35e58d2-869d-40bf-a00e-296a9d3bb659", "openfda": {"nui": ["N0000191279", "N0000000150", "M0002832"], "unii": ["K124A4EUQ3"], "rxcui": ["1543177"], "spl_set_id": ["22a6617b-d4b1-405e-901a-0b39a7b2837d"], "pharm_class_cs": ["Boron Compounds [CS]"], "pharm_class_epc": ["Oxaborole Antifungal [EPC]"], "pharm_class_moa": ["Protein Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, DROPPER in 1 CARTON (62332-467-04)  / 4 mL in 1 BOTTLE, DROPPER", "package_ndc": "62332-467-04", "marketing_start_date": "20201023"}, {"sample": false, "description": "1 BOTTLE, DROPPER in 1 CARTON (62332-467-10)  / 10 mL in 1 BOTTLE, DROPPER", "package_ndc": "62332-467-10", "marketing_start_date": "20201023"}], "brand_name": "Tavaborole", "product_id": "62332-467_d35e58d2-869d-40bf-a00e-296a9d3bb659", "dosage_form": "SOLUTION", "pharm_class": ["Boron Compounds [CS]", "Oxaborole Antifungal [EPC]", "Protein Synthesis Inhibitors [MoA]"], "product_ndc": "62332-467", "generic_name": "Tavaborole", "labeler_name": "Alembic Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tavaborole", "active_ingredients": [{"name": "TAVABOROLE", "strength": "43.5 mg/mL"}], "application_number": "ANDA212188", "marketing_category": "ANDA", "marketing_start_date": "20201023", "listing_expiration_date": "20261231"}